Alpha-Gal Syndrome (AGS) Clinical Trials and Treatments

From that point forward, eating mammalian meat or other alpha-gal-containing products can trigger an allergic reaction. Importantly, having a positive alpha-gal IgE blood test does not by itself mean a patient is clinically allergic. Some people have detectable IgE without symptoms (sensitization without clinical allergy). A CDC study of 3,000 blood donor samples across 10 states, published in July 2026, found alpha-gal IgE in 31.2% of donors tested in Arkansas and 1.1% in Washington, and said only a small minority of people who test positive have the syndrome. True diagnosis of AGS requires both a positive sIgE test and a history of clinical reactions to mammalian products.

What makes AGS clinically unique is the delay. Most food allergies cause symptoms within minutes of eating the trigger. AGS reactions usually appear 2 to 6 hours after eating red meat or dairy, according to the CDC. The leading explanation for the delay is that alpha-gal in meat travels on fat molecules called glycolipids and is absorbed slowly along with dietary fat. A 2019 lab study in the journal Allergy found that alpha-gal bound to fats, not proteins, crossed a layer of gut cells in a form that could still trigger allergy cells. This delayed pattern is a major reason AGS goes undiagnosed for so long: patients and doctors often fail to connect a 9 PM hive outbreak to a 3 PM steak lunch.

The range of triggers extends well beyond red meat. Dairy products can trigger reactions in some patients (because milk fat contains small amounts of alpha-gal). Gelatin, which is derived from cattle and pigs, is present in many candies, marshmallows, vaccine stabilizers, and capsules.

Heparin (an anticoagulant), porcine-derived surgical glues, certain monoclonal antibodies (notably cetuximab, whose 2008 anaphylaxis cases were the diagnostic clue that led to AGS being identified), bovine and porcine heart valve implants, and many cosmetic and personal-care products can all contain alpha-gal.

In August 2026, AABB, which accredits many US hospital blood banks, also described severe reactions in blood type O patients with alpha-gal antibodies who received platelets or plasma from type B or AB donors, a link it calls hypothesized. Trial Friend's guide to alpha-gal and blood transfusions explains what to tell a hospital before surgery.

The complete avoidance list is significantly longer than red meat alone, which is why AGS patients need a comprehensive medication and product safety plan.

Diagnosis is confirmed by a blood test for IgE antibodies specific to alpha-gal (sometimes called the alpha-gal sIgE or galactose-α-1,3-galactose IgE test). In the diagnostic criteria used by Dr. Scott Commins's group, a result above 0.1IU/mL counts as positive, and clinical correlation always guides interpretation rather than the number alone. The test is widely available through Quest Diagnostics, Viracor, and other major labs.

Skin prick testing is less reliable than blood IgE for AGS specifically. Some AGS patients also have features that overlap with mast cell activation (flushing, brain fog, GI symptoms outside of meal-related reactions, elevated baseline tryptase), and some hold concurrent MCAS diagnoses.

A University of North Carolina study that is not yet recruiting (NCT07526558) will compare the mast cell stabilizers ketotifen and cromolyn, added to the antihistamine fexofenadine, with fexofenadine alone in adults aged 21 to 65 with lasting mast cell symptoms after a tick-borne illness, including AGS. Once diagnosed, management is centered on avoidance of alpha-gal-containing foods, medications, and medical products, with epinephrine auto-injectors prescribed for emergencies.

There is no FDA-approved cure or disease-modifying treatment for AGS. Some patients see IgE titers fall over time when no further tick bites occur, and a subset can eventually reintroduce mammalian meat under medical supervision. Subsequent tick bites can re-sensitize patients and worsen the condition.